Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 025321/0502 | |
| Pages: | 9 |
| | Recorded: | 11/08/2010 | | |
| Attorney Dkt #: | 033619.00101 |
| Conveyance: | SECURITY AGREEMENT |
|
|
Total properties:
6
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/13/2004
|
Application #:
|
09812024
|
Filing Dt:
|
03/19/2001
|
|
Publication #:
|
|
Pub Dt:
|
01/23/2003
| | | | |
|
Title:
|
PROCESS FOR PRODUCING WET RIBAVIRIN PELLETS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/26/2009
|
Application #:
|
10882358
|
Filing Dt:
|
07/02/2004
|
|
Publication #:
|
|
Pub Dt:
|
01/27/2005
| | | | |
|
Title:
|
COMPOSITION CONTAINING RIBAVIRIN AND USE THEREOF
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/25/2010
|
Application #:
|
11201311
|
Filing Dt:
|
08/11/2005
|
|
Publication #:
|
|
Pub Dt:
|
04/20/2006
| | | | |
|
Title:
|
LARGE DOSE RIBAVIRIN FORMULATIONS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
12180139
|
Filing Dt:
|
09/19/2008
|
|
Publication #:
|
|
Pub Dt:
|
01/08/2009
| | | | |
|
Title:
|
LARGE DOSE RIBAVRIN FORMULATONS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
12420459
|
Filing Dt:
|
04/08/2009
|
|
Publication #:
|
|
Pub Dt:
|
09/10/2009
| | | | |
|
Title:
|
CONTINUOUS DELIVERY METHODS FOR TREATING HEPATITIS VIRUS INFECTION
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
12761869
|
Filing Dt:
|
04/16/2010
|
|
Publication #:
|
|
Pub Dt:
|
08/12/2010
| | | | |
|
Title:
|
LARGE DOSE RIBAVIRIN FORMULATIONS
|
|
|
Assignee
|
|
|
|
|
| 225 W. WASHINGTON STREET |
| SUITE 1450 |
| CHICAGO, ILLINOIS 60606 |
|
|
Correspondence name and address
|
| |
COVINGTON & BURLING
|
| |
1201 PENNSYLVANIA AVENUE, NW
|
| |
ATTN: PATENT DOCKETING
|
| |
WASHINGTON, DC 20004-2401
|
Search Results as of:
05/31/2024 02:45 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
